These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8566182)

  • 21. Efficacy of immunosuppressive drugs in islet xenotransplantation: leflunomide in combination with cyclosporine and mycophenolate mofetil prevents islet xenograft rejection in the pig-to-rat model.
    Wennberg L; Karlsson-Parra A; Sundberg B; Rafael E; Liu J; Zhu S; Groth CG; Korsgren O
    Transplantation; 1997 May; 63(9):1234-42. PubMed ID: 9158015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effects of immunosuppressants and steroids against ischemia-reperfusion injury in cremaster muscle flap at microcirculatory level.
    Askar I; Bozkurt M
    Microsurgery; 2002; 22(8):361-6. PubMed ID: 12497573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor specific transfusion in kidney transplantation: effect of different immunosuppressive protocols on graft outcome.
    Barbari A; Stephan A; Masri MA; Joubran N; Dagher O; Kamel G
    Transplant Proc; 2001 Aug; 33(5):2787-8. PubMed ID: 11498161
    [No Abstract]   [Full Text] [Related]  

  • 25. Improvement in long-term graft survival in cadaveric renal transplant recipients treated with mycophenolate mofetil.
    Hazzan M; Provot F; Glowacki F; Copin MC; Roumilhac D; Labalette M; Pruvot FR; Noel C
    Transpl Int; 2004 Oct; 17(9):525-30. PubMed ID: 15338120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated immune responses in renal transplant recipients treated with cyclosporin and prednisolone with or without azathioprine.
    Wramner L; Mjörnstedt L; Rydberg L; Olausson M
    Scand J Immunol; 1993 Jun; 37(6):656-60. PubMed ID: 8316763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of cyclosporin versus azathioprine treatment in renal transplants in Edinburgh.
    Notghi A; Dick J; Smith G; Anderton JL; Chisholm GD
    Scott Med J; 1989 Jun; 34(3):459-62. PubMed ID: 2665071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of LS-2616 on the graft protection achieved by cyclosporin A, prednisolone, and 15-deoxyspergualin in heart-transplanted rats.
    Wanders A; Gannedahl G; Gerdin B; Tufveson G
    Transpl Int; 1992; 5 Suppl 1():S462-3. PubMed ID: 14621847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microemulsified cyclosporine-based immunosuppression for the prevention of acute renal allograft rejection in unrelated dogs: preliminary experimental study.
    Bernsteen L; Gregory CR; Kyles AE; Griffey SM; Patz J
    Vet Surg; 2003; 32(3):213-9. PubMed ID: 12784197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine A and azathioprine are equipotent in chronic kidney allograft rejection.
    Hamar P; Liu S; Viklický O; Szabó A; Múller V; Heemann U
    Transplantation; 2000 Apr; 69(7):1290-5. PubMed ID: 10798743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term graft survival after conversion from cyclosporin to azathioprine 1 year after renal transplantation. A prospective, randomized study from 1 to 6 years after transplantation.
    Pedersen EB; Hansen HE; Kornerup HJ; Madsen S; Sørensen AW
    Nephrol Dial Transplant; 1993; 8(3):250-4. PubMed ID: 8385294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage.
    Sumethkul V; Jirasiritham S; Chiewsilp P
    Transplant Proc; 1996 Jun; 28(3):1461-2. PubMed ID: 8658741
    [No Abstract]   [Full Text] [Related]  

  • 33. Relevance of maintenance triple-drug immunosuppression to bridle the amplification of rat cytomegalovirus infection after experimental lung transplantation.
    Lehle K; von Suesskind-Schwendi M; Diez C; Michl M; Geissler EK; Wottge HU; Schmid C; Hirt SW
    Transpl Infect Dis; 2012 Dec; 14(6):649-56. PubMed ID: 22676701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trial of steroid withdrawal in renal transplant recipients with long-term--surviving allograft.
    Mizuno Y; Kikuchi H; Fujimori K; Doi H; Orii T; Ohkohchi N; Satomi S
    Transplant Proc; 2000 Nov; 32(7):1677-8. PubMed ID: 11119888
    [No Abstract]   [Full Text] [Related]  

  • 35. BTI-322 for induction therapy after renal transplantation: a randomized study.
    Squifflet JP; Besse T; Malaise J; Mourad M; Delcorde C; Hope JA; Pirson Y
    Transplant Proc; 1997; 29(1-2):317-9. PubMed ID: 9123018
    [No Abstract]   [Full Text] [Related]  

  • 36. Daclizumab: novel biologic immunoprophylaxis for prevention of acute rejection in renal transplantation.
    Vincenti F
    Transplant Proc; 1999 Sep; 31(6):2206-7. PubMed ID: 10500546
    [No Abstract]   [Full Text] [Related]  

  • 37. Methylprednisolone prevents rejection of intrastriatal grafts of xenogeneic embryonic neural tissue in adult rats.
    Duan WM; Brundin P; Grasbon-Frodl EM; Widner H
    Brain Res; 1996 Mar; 712(2):199-212. PubMed ID: 8814894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective randomized study of azathioprine versus cyclosporin in live-donor kidney transplantation.
    Ghoneim MA; Sobh MA; Shokeir AA; Bakr MA; el-Sherif AK; Fouda MA
    Am J Nephrol; 1993; 13(6):437-41. PubMed ID: 8141177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcineurin inhibitors in renal transplantation: what is the best option?
    Tanabe K
    Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Porcine neural xenografts in rats and mice: donor tissue development and characteristics of rejection.
    Larsson LC; Frielingsdorf H; Mirza B; Hansson SJ; Anderson P; Czech KA; Strandberg M; Widner H
    Exp Neurol; 2001 Nov; 172(1):100-14. PubMed ID: 11681844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.